The Antiangiogenic Agent SU5416 Down-Regulates Phorbol Ester-Mediated Induction of Cyclooxygenase 2 Expression by Inhibiting Nicotinamide Adenine Dinucleotide Phosphate Oxidase Activity

Cancer Research

Volumn 63, Issue 20, 2003, Pages 6920-6927

  Saha, Debabrata ^a   Sekhar, Konjeti R ^a   Cao, Carolyn ^a   Morrow, Jason D ^a   Choy, Hak ^a,b   Freeman, Michael L ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ANGIOGENESIS INHIBITOR; CYCLOOXYGENASE 2; DIPHENYLIODONIUM SALT; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SEMAXANIB;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LARGE CELL CARCINOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION;

ANGIOGENESIS INHIBITORS; CARCINOMA, NON-SMALL-CELL LUNG; CYCLOOXYGENASE 2; DOWN-REGULATION; DRUG INTERACTIONS; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDOLES; ISOENZYMES; LUNG NEOPLASMS; MEMBRANE PROTEINS; NADPH OXIDASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRROLES; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE;

EID: 0142157654     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (Wash. DC), 246: 1306-1309, 1989.
2. Ferrara, N. Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med., 77: 527-543, 1999.
3. Laird, A. D., Vajkoczy, P., Shawver, L. K., Thurnher, A., Liang, C., Mohammadi, M., Schlessinger, J., Ullrich, A., Hubbard, S. R., Blake, R. A., Fong, T. A., Strawn, L. M., Sun, L., Tang, C., Hawtin, R., Tang, F., Shenoy, N., Hirth, K. P., McMahon, G., and Cherrington, J. M. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Res., 60: 4152-4160, 2000.
4. Fong, T. A., Shawver, L. K., Sun, L., Tang, C., App, H., Powell, T. J., Kim, Y. H., Schreck, R., Wang, X., Risau, W., Ullrich, A., Hirth, K. P., and McMahon, G. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res., 59: 99-106, 1999.
5. Marnett, L. J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52: 5575-5589, 1992.
6. Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell, 83: 483-492, 1995.
7. Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell, 83: 473-482, 1995.
8. Smith, W. L., and Dewitt, D. L. Prostaglandin endoperoxide H synthases-1 and -2. Adv. Immunol., 62: 167-215, 1996.
9. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995.
10. Fletcher, B. S., Kujubu, D. A., Perrin, D. M., and Herschman, H. R. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J. Biol. Chem., 267: 4338-4344, 1992.
11. Yokoyama, C., and Tanabe, T. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem. Biophys. Res. Commun., 165: 888-894, 1989.
12. Williams, C. S., and DuBois, R. N. Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol., 270: G393-G400, 1996.
13. O'Neill, G. P., and Ford-Hutchinson, A. W. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett., 330: 156-160, 1993.
14. Jacoby, R. F., Marshall, D. J., Newton, M. A., Novakovic, K., Tutsch, K., Cole, C. E., Lubet, R. A., Kelloff, G. J., Verma, A., Moser, A. R., and Dove, W. F. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res., 56: 710-714, 1996.
15. Kawamori, T., Rao, C. V., Seibert, K., and Reddy, B. S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58: 409-412, 1998.
16. Reddy, B. S., Rao, C. V., and Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56: 4566-4569, 1996.
17. Williams, C. S., Luongo, C., Radhika, A., Zhang, T., Lamps, L. W., Nanney, L. B., Beauchamp, R. D., and DuBois, R. N. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology, 111: 1134-1140, 1996.
18. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., and Takahashi, T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res., 58: 3761-3764, 1998.
19. Soslow, R. A., Dannenberg, A. J., Rush, D., Woerner, B. M., Khan, K. N., Masferrer, J., and Koki, A. T. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer (Phila.), 89: 2637-2645, 2000.
20. Wolff, H., Saukkonen, K., Anttila, S., Karjalainen, A., Vainio, H., and Ristimaki, A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res., 58: 4997-5001, 1998.
21. Achiwa, H., Yatabe, Y., Hida, T., Kuroishi, T., Kozaki, K., Nakamura, S., Ogawa, M., Sugiura, T., Mitsudomi, T., and Takahashi, T. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin. Cancer Res., 5: 1001-1005, 1999.
22. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716, 1998.
23. Tsujii, M., Kawano, S., and DuBois, R. N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA, 94: 3336-3340, 1997.
24. Williams, C. S., Tsujii, M., Reese, J., Dey, S. K., and DuBois, R. N. Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Investig., 105: 1589-1594, 2000.
25. Jones. M. K., Wang, H., Peskar, B. M., Levin, E., Itani, R. M., Sarfeh, I. J., and Tarnawski, A. S. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat. Med., 5: 1418-1423, 1999.
26. Form, D. M., and Auerbach, R. PGE2 and angiogenesis. Proc. Soc. Exp. Biol. Med., 172: 214-218, 1983.
27. Harada, S., Nagy, J. A., Sullivan, K. A., Thomas, K. A., Endo, N., Rodan, G. A., and Rodan, S. B. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J. Clin. Investig., 93: 2490-2496, 1994.
28. Heasley, L. E., Thaler, S., Nicks, M., Price, B., Skorecki, K., and Nemenoff, R. A. Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer. J. Biol. Chem., 272: 14501-14504, 1997.
29. Pagano, P. J., Clark, J. K., Cifuentes-Pagano, M. E., Clark, S. M., Callis, G. M., and Quinn, M. T. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc. Natl. Acad. Sci. USA, 94: 14483-14488, 1997.
30. Mohazzab, K. M., and Wolin, M. S. Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle. Am. J. Physiol., 267: L815-L822, 1994.
31. Flohe, L., and Otting, F. Superoxide dismutase assays. Methods Enzymol., 105: 93-104, 1984.
32. 2-production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils. Methods Enzymol., 105: 358-365, 1984.
33. Subbaramaiah, K., Cole, P. A., and Dannenberg, A. J. Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms. Cancer Res., 62: 2522-2530, 2002.
34. Sheng, H., Shao, J., and DuBois, R. N. Akt/PKB activity is required for Ha-Ras-mediated transformation of intestinal epithelial cells. J. Biol. Chem., 276: 14498-14504, 2001.
35. Saha, D., Datta, P. K., Sheng, H., Morrow, J. D., Wada, M., Moses, H. L., and Beauchamp, R. D. Synergistic induction of cyclooxygenase-2 by transforming growth factor β1 and epidermal growth factor inhibits apoptosis in epithelial cells. Neoplasia, 1: 508-517, 1999.
36. Rajagopalan, L. E., and Malter, J. S. Turnover and translation of in vitro synthesized messenger RNAs in transfected, normal cells. J. Biol. Chem., 271: 19871-19876, 1996.
37. Chen, C. S. Phorbol ester induces elevated oxidative activity and alkalization in a subset of lysosomes. BMC Cell Biol., 3: 21, 2002.
38. Feng, L., Xia, Y., Garcia, G. E., Hwang, D., and Wilson, C. B. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor α, and lipopolysaccharide. J. Clin. Investig., 95: 1669-1675, 1995.
39. Chen, L., Yu, L. J., and Waxman, D. J. Potentiation of cytochrome P450/cyclophosphamide-based cancer gene therapy by coexpression of the P450 reductase gene. Cancer Res., 57: 4830-4837, 1997.
40. Rusyn, I., Yamashina, S., Segal, B. H., Schoonhoven, R., Holland, S. M., Cattley, R. C., Swenberg, J. A., and Thurman, R. G. Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators. Cancer Res., 60: 4798-4803, 2000.
41. Rieger, J. M., Shah, A. R., and Gidday, J. M. Ischemia-reperfusion injury of retinal endothelium by cyclooxygenase- and xanthine oxidase-derived superoxide. Exp. Eye Res., 74: 493-501, 2002.
42. Murakami, A., Takahashi, D., Kinoshita, T., Koshimizu, K., Kim, H. W., Yoshihiro, A., Nakamura, Y., Jiwajinda, S., Terao, J., and Ohigashi, H. Zerumbone, a Southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the α, β-unsaturated carbonyl group is a prerequisite. Carcinogenesis (Lond.), 23: 795-802, 2002.
43. Gottschling, B. C., Maronpot, R. R., Hailey, J. R., Peddada, S., Moomaw, C. R., Klaunig, J. E., and Nyska, A. The role of oxidative stress in indium phosphide-induced lung carcinogenesis in rats. Toxicol. Sci., 64: 28-40, 2001.
44. Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J. M., and Dannenberg, A. J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem., 273: 21875-21882, 1998.
45. Datta, R., Yoshinaga, K., Kaneki, M., Pandey, P., and Kufe, D. Phorbol ester-induced generation of reactive oxygen species is protein kinase C β-dependent and required for SAPK activation. J. Biol. Chem., 275: 41000-41003, 2000.
46. Martinez-Salgado, C., Eleno, N., Tavares, P., Rodriguez-Barbero, A., Gracia-Criado, J., Bolanos, J. P., and Lopez-Novoa, J. M. Involvement of reactive oxygen species on gentamicin-induced mesangial cell activation. Kidney Int., 62: 1682-1692, 2002.
47. Maihofner, C., Charalambous, M. P., Bhambra, U., Lightfoot, T., Geisslinger, G., and Gooderham, N. J. Expression of cyclooxygenase-2 parallels expression of interleukin-1β, interleukin-6 and NF-κB in human colorectal cancer. Carcinogenesis (Lond.), 24: 665-671, 2003.
48. Bonizzi, G., Piette, J., Schoonbroodt, S., Greimers, R., Havard, L., Merville, M. P., and Bours, V. Reactive oxygen intermediate-dependent NF-κB activation by interleukin-1β requires 5-lipoxygenase or NADPH oxidase activity. Mol. Cell. Biol., 19: 1950-1960, 1999.
49. Gu, Y., Xu, Y. C., Wu, R. F., Nwariaku, F. E., Souza, R. F., Flores, S. C., and Terada, L. S. p47phox participates in activation of RelA in endothelial cells. J. Biol. Chem., 278: 17210-17217, 2003.
50. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
51. Fontanini, G., Vignati, S., Boldrini, L., Chine, S., Silvestri, V., Lucchi, M., Mussi, A., Angeletti, C. A., and Bevilacqua, G. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin. Cancer Res., 3: 861-865, 1997.
52. Fontanini, G., Lucchi, M., Vignati, S., Mussi, A., Ciardiello, F., De Laurentiis, M., De Placido, S., Basolo, F., Angeletti, C. A., and Bevilacqua, G. Angiogenesis as a prognostic indicator of survival in non-small cell lung carcinoma: a prospective study. J. Natl. Cancer Inst. (Bethesda), 89: 881-886, 1997.
53. Macchiarini, P., Fontanini, G., Dulmet, E., de Montpreville, V., Chapelier, A. R., Cerrina, J., Ladurie, F. L., and Dartevelle, P. G. Angiogenesis: an indicator of metastasis in non-small cell lung cancer invading the thoracie inlet. Ann. Thorac. Surg., 57: 1534-1539, 1994.
54. Volm, M., Mattern, J., and Koomagi, R. Expression of platelet-derived endothelial cell growth factor in non-small cell lung carcinomas: relationship to various biological factors. Int. J. Oncol., 13: 975-979, 1998.
55. Heldin, C. H. Protein tyrosine kinase receptors. Cancer Surv., 27: 7-24, 1996.
56. 2 for platelet-derived growth factor signal transduction. Science (Wash. DC), 270: 296-299, 1995.
57. Ych, L. H., Park, Y. J., Hansalia, R. J., Ahmed, I. S., Deshpande, S. S., Goldschmidt-Clermont, P. J., Irani, K., and Alevriadou, B. R. Shear-induced tyrosine phosphorylation in endothelial cells requires Rac1-dependent production of ROS. Am. J. Physiol., 276: C838-C847, 1999.
58. Ushio-Fukai, M., Alexander, R. W., Akers, M., Yin, Q., Fujio, Y., Walsh, K., and Griendling, K. K. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin 11 in vascular smooth muscle cells. J. Biol. Chem., 274: 22699-22704, 1999.
59. Baichwal, V. R., and Baeuerle, P. A. Activate NF-κB or die? Curr. Biol., 7: R94-R96, 1997.
60. Gerber, H. P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V., and Ferrara, N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem., 273: 30336-30343, 1998.
61. Gupta, K., Kshirsagar, S., Li, W., Gui, L., Ramakrishnan, S., Gupta, P., Law, P. Y., and Hebbel, R. P. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp. Cell Res., 247: 495-504, 1999.
62. Abid, M. R., Kachra, Z., Spokes, K. C., and Aird, W. C. NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Lett., 486: 252-256, 2000.
63. Ushio-Fukai, M. T. Y., Fukai, T., Dikalov, S. I., Ma, Y., Fujimoto, M., Quinu, M. T., Pagano, P. J., Johnson, C., and Alexander, R. W. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ. Res., 91: 1160-1167, 2002.